Glargine and lispro: two cases of mistaken identity.
Adlersberg
Marcy A
MA
Section of Endocrinology, Department of Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Fernando
Surani
S
Spollett
Geralyn R
GR
Inzucchi
Silvio E
SE
D000328:Adult; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D004348:Drug Labeling / Q000592:standards; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007328:Insulin / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D000069036:Insulin Glargine; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D008508:Medication Errors; D008875:Middle Aged; D012646:Self Administration
D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine